Earlier today, President Trump announced a deal to drastically lower the price of some popular weight loss drugs for some Americans. Under the deal, Eli Lilly, the maker of Zepbound, and Novo Nordisk, the company behind Ozempic and Wegovy, have agreed to lower the price of their weight loss drugs for eligible patients on Medicare, Medicaid and for eligible users of the planned "TrumpRx" pharmaceutical website. "This will slash the cost of Wegovy from $1,350 a month to ultimately $250 a month," P

The Trump administration has announced deals with pharmaceutical giants Novo Nordisk and Eli Lilly, which includes Wegovy and Zepbound. Medicare and Medicaid to cover the drugs for qualified patients. Mary Bruce has details. https://abcnews.link/MZbnbhe | ABC World News Tonight with David Muir